Shares of HealthStream, Inc. (NASDAQ:HSTM) have been given an average recommendation of “Buy” by the ten research firms that are presently covering the firm, MarketBeat reports. Five equities research analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average twelve-month target price among analysts that have updated their coverage on the stock in the last year is $26.17.
A number of equities research analysts have recently weighed in on HSTM shares. ValuEngine cut HealthStream from a “hold” rating to a “sell” rating in a research note on Thursday, March 1st. Zacks Investment Research raised HealthStream from a “hold” rating to a “buy” rating and set a $28.00 price objective for the company in a research note on Thursday, May 3rd. BidaskClub raised HealthStream from a “hold” rating to a “buy” rating in a research note on Saturday. Barrington Research reaffirmed a “buy” rating and issued a $32.00 price objective on shares of HealthStream in a research note on Thursday, April 26th. Finally, Cantor Fitzgerald reaffirmed a “hold” rating and issued a $24.00 price objective on shares of HealthStream in a research note on Monday, February 12th.
HSTM stock traded up $0.08 during midday trading on Monday, hitting $27.78. 66,400 shares of the company’s stock were exchanged, compared to its average volume of 120,628. The stock has a market cap of $894.78 million, a price-to-earnings ratio of 102.89, a price-to-earnings-growth ratio of 5.41 and a beta of 0.75. HealthStream has a 1-year low of $21.15 and a 1-year high of $31.53.
In related news, Director C Martin Harris sold 10,452 shares of the business’s stock in a transaction on Thursday, March 1st. The stock was sold at an average price of $24.06, for a total transaction of $251,475.12. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Gerard M. Hayden, Jr. sold 14,226 shares of the business’s stock in a transaction on Tuesday, May 15th. The stock was sold at an average price of $26.99, for a total value of $383,959.74. Following the transaction, the chief financial officer now directly owns 30,290 shares of the company’s stock, valued at $817,527.10. The disclosure for this sale can be found here. Insiders have sold a total of 145,623 shares of company stock valued at $3,628,877 over the last three months. 20.60% of the stock is currently owned by insiders.
Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Stevens Capital Management LP acquired a new position in HealthStream during the 1st quarter worth $203,000. Victory Capital Management Inc. acquired a new position in HealthStream during the 1st quarter worth $210,000. Teacher Retirement System of Texas acquired a new position in HealthStream during the 4th quarter worth $215,000. Barclays PLC grew its stake in HealthStream by 45.6% during the 1st quarter. Barclays PLC now owns 9,444 shares of the technology company’s stock worth $235,000 after purchasing an additional 2,958 shares in the last quarter. Finally, Campbell & CO Investment Adviser LLC acquired a new position in HealthStream during the 1st quarter worth $241,000. 70.93% of the stock is owned by hedge funds and other institutional investors.
HealthStream Company Profile
HealthStream, Inc provides workforce and provider solutions to the healthcare organizations in the United States. It operates in HealthStream Workforce Solutions and HealthStream Provider Solutions segments. The company offers workforce development solutions comprising software-as-a-service (SaaS) and subscription-based products to meet talent management, training, certification, competency assessment, performance appraisal, and development needs, as well as training, implementation, and account management services.
Receive News & Ratings for HealthStream Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthStream and related companies with MarketBeat.com's FREE daily email newsletter.